Thymine

Thymine

SCHEMBL3972004

C1COCO1.Cc1c[nH]c(=O)[nH]c1=O.NP(=O)(O)O

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ATAD2 Q6PL18 1/20 0.56
▸ GAA P10253 2/20 0.36
▸ DPYD Q12882 4/20 0.33
▸ LMNA P02545 3/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ CYP19A1 P11511 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ THPO P40225 1/20 0.33
▸ MTOR P42345 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ HBB P68871 1/20 0.33
▸ PMP22 Q01453 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ POLB P06746 1/20 0.31
▸ KLF10 Q13118 1/20 0.30
▸ KDM4C Q9H3R0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Thymine SCHEMBL211722 0.89 ATAD2 (0.70) ATAD2GAADPYDLMNAALDH1A1
Thymine SCHEMBL3972000 0.88 ATAD2 (0.56) ATAD2GAADPYDLMNAALDH1A1
Thymine SCHEMBL3364510 0.81 ATAD2 (0.79) ATAD2GAADPYDLMNAALDH1A1
Thymine SCHEMBL4349014 0.81 ATAD2 (0.79) ATAD2GAADPYDLMNAALDH1A1
Thymine SCHEMBL188134 0.81 ATAD2 (0.79) ATAD2GAADPYDLMNAALDH1A1
Thymine SCHEMBL1452487 0.81 ATAD2 (0.79) ATAD2GAADPYDLMNAALDH1A1
Thymine SCHEMBL28570793 0.79 ATAD2 (0.76) ATAD2GAADPYDLMNAALDH1A1
Thymine SCHEMBL28575361 0.79 ATAD2 (0.76) ATAD2GAADPYDLMNAALDH1A1
Thymine SCHEMBL6911382 0.77 ATAD2 (0.73) ATAD2GAADPYDLMNAALDH1A1
Thymine SCHEMBL8304490 0.77 ATAD2 (0.86) ATAD2GAADPYDLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009052050-A1 DIOXOLANE THYMINE PHOSPHORAMIDATES AS ANTI-HIV AGENTS PHARMASSET, INC. (US) 2009-04-23 — — WO disclosed
WO-2009052050-A1 DIOXOLANE THYMINE PHOSPHORAMIDATES AS ANTI-HIV AGENTS PHARMASSET, INC. (US) 2009-04-23 — — WO disclosed
US-20090099136-A1 DIOXOLANE THYMINE PHOSPHORAMIDATES AS ANTI-HIV AGENTS PHARMASSET, INC. (US) 2009-04-16 — — US disclosed
US-20090099136-A1 DIOXOLANE THYMINE PHOSPHORAMIDATES AS ANTI-HIV AGENTS PHARMASSET, INC. (US) 2009-04-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090099136-A1 DIOXOLANE THYMINE PHOSPHORAMIDATES AS ANTI-HIV AGENTS TYMP, DTYMK, TYMS ATAD2 3904/4885GAA 723/4885DPYD 20/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback